Dennis Veldhuizen

CD34+CD38− leukemic stem cell frequency to predict outcome in acute myeloid leukemia

Wendelien Zeijlemaker, Tim Grob, Rosa Meijer et al. · Leukemia · 2018 · 200 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +10

Impact of the tumor microenvironment on prognosis in follicular lymphoma is dependent on specific treatment protocols

Daphne de Jong, Ad Koster, Anton Hagenbeek et al. · Haematologica · 2008 · 144 citations · Full text

A simple one-tube assay for immunophenotypical quantification of leukemic stem cells in acute myeloid leukemia

Wendelien Zeijlemaker, Angèle Kelder, Yvonne J.M Oussoren-Brockhoff et al. · Leukemia · 2015 · 121 citations

Hematological Malignancy, Medicine, Acute Myeloid Leukemia +13

Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia

Wendelien Zeijlemaker, Angèle Kelder, Yvonne J.M Oussoren-Brockhoff et al. · Leukemia · 2015 · 82 citations

Hematological Malignancy, Bone Marrow Failure, Mixed-phenotype Acute Leukemia +10

Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia

Jacqueline Cloos, Jeffrey R. Harris, Jeroen J. W. M. Janssen et al. · Journal of Visualized Experiments · 2018 · 36 citations · Full text

Mixed-phenotype Acute Leukemia, Immunology, Pathology +19